J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

New University obtained a UFCW CVS bargaining committee statement representing their stance. UFCW Local 770, which ...

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...

She came to CVS Health when the company acquired its Aetna division several years ago. Her tenure started with the company’s drugstores riding a wave of revenue from COVID-19 vaccines.

CVS replaces its CEO on Friday and cut its third ... The Details: The end of the COVID-19 public health emergency triggered significant changes to Medicaid coverage, including the end of the ...

CVS Health (NYSE: CVS ... the costs from this plan to continue to rise due to higher operating costs post-Covid. Aetna’s ratings have experienced significant fluctuations over the past few ...

She came to CVS Health when the company acquired its Aetna division several years ago. Her tenure started with the company’s drugstores riding a wave of revenue from COVID-19 vaccines.

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive ... and led the company through the Covid-19 pandemic, overseeing the rollout ...